Bridgewater, United States
Solaris Pharma Corporation was founded in 2014 with the vision of improving the patients’ quality of life through the development of niche pharmaceutical products. Located in Bridgewater, New Jersey, the company has a fully equipped Research & Development facility with expertise in the development of generic and specialty products. Solaris Pharma Corporation is uniquely poised to develop specialty dermatology products that have a relatively high barrier to entry due to manufacturing complexities and high-end clinical patient study demands.
With a thorough knowledge of the development life cycle and well-trained, committed scientific personnel, Solaris Pharma Corporation has streamlined processes that are efficient in reducing development costs and shortening timelines, without compromise in quality. The company is currently engaged in the development of several generic dermatology products and is committed to establishing itself as a pacesetter in dermatology pharmaceuticals.
The last investment in Solaris Pharma Corporation was a $10.00M Venture Round investment on 09 December 2019.
TARO PHARMACEUTICALS CANADA
